The heme oxygenase/biliverdin reductase pathway in drug research and development

Current Drug Metabolism

Volumn 10, Issue 6, 2009, Pages 579-594

  Mancuso, C ^a   Barone, E ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bilirubin; Biliverdin reductase; Carbon monoxide; Drug research and development; Heme oxygenase; Nitric oxide

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; BILIRUBIN; BILIVERDIN REDUCTASE; CARBON MONOXIDE; CARDIOVASCULAR AGENT; CHLORPROMAZINE; CYCLOSPORIN A; DOXORUBICIN; FLUNARIZINE; HEME OXYGENASE; HEME OXYGENASE 1; HEME OXYGENASE 2; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMATINIB; IMMUNOSUPPRESSIVE AGENT; IRON; LOSARTAN; MORPHINE; OPIATE DERIVATIVE; ORGANIC NITRATE; OXIDOREDUCTASE; QUETIAPINE; RAPAMYCIN; SARTAN DERIVATIVE; SILDENAFIL; TRANILAST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE;

ALLERGY; ALZHEIMER DISEASE; ANGINA PECTORIS; BREAST CANCER; CARDIOMYOPATHY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEPRESSION; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESEARCH; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ERECTILE DYSFUNCTION; GRAFT REJECTION; HEART FAILURE; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; ISCHEMIA; LOW DRUG DOSE; LUNG SMALL CELL CANCER; LYMPHOMA; MIGRAINE; MYELOID LEUKEMIA; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSYCHOSIS; PULMONARY HYPERTENSION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR;

ANTIOXIDANTS; HEME OXYGENASE (DECYCLIZING); HUMANS; OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS;

EID: 70450137050     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009789375405     Document Type: Review

References (247)

1. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J., 1988, 2(10), 2557-2568.
2. Maines, M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 517-554.
3. Stocker, R.; Yamamoto, Y.; McDonagh, A.F.; Glazer, A.N.; Ames, B.N. Bilirubin is an antioxidant of possible physiological importance. Science, 1987, 235, 1043-1046.
4. Verma, A.; Hirsch, D.J.; Glatt, C.E.; Ronnett, G.V.; Snyder, S.H.; Carbon monoxide: a putative neural messenger. Science, 1993, 259, 381-384. (Pubitemid 23055683)
5. Wu, L.; Wang, R. Carbon monoxide: endogenous production, physiological functions,and pharmacological applications. Pharmacol. Rev., 2005 , 7(4), 585-630. (Pubitemid 43036442)
6. Mancuso, C.; Capone, C.; Ranieri, S.C.; Fusco, S.; Calabrese, V.; Eboli, M.L.; Preziosi, P.; Galeotti, T.; Pani, G. Bilirubin as an endogenous modulator of neurotrophin redox signaling. J. Neurosci. Res., 2008, 86(10), 2235-2249.
7. Piantadosi, C.A. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic. Biol. Med., 2008, 45(5), 562-569.
8. Mancuso, C.; Bonsignore, A.; Capone, C.; Di Stasio, E.; Pani, G. Albumin-bound bilirubin interacts with nitric oxide by a redox mechanism. Antioxid. Redox. Signal., 2006, 8(3-4), 487-494. (Pubitemid 43741317)
9. Mancuso, C.; Pani, G.; Calabrese, V. Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox. Rep., 2006, 11(5)., 207-213. (Pubitemid 44741627)
10. Stocker, R. Antioxidant activities of bile pigments. Antioxid. Redox. Signal., 2004, 6(5), 841-849.
11. Mancuso, C.; Bonsignore, A.; Di Stasio, E.; Mordente, A.; Motterlini, R. Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide. Biochem. Pharmacol., 2003, 66(12), 2355-2363.
12. Calabrese, V.; Cornelius, C., Mancuso, C.; Pennisi, G.; Calafato, S.; Bellia, F.; Bates, T.E.; Giuffrida Stella, A.M.; Schapira, T.; Dinkova Kostova, A.T.; Rizzarelli, E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem. Res., 2008, 33(12), 2444-2471.
13. Mancuso, C.; Scapagnini, G.; Currò, D.; Giuffrida Stella, A.M.; De Marco, C.; Butterfield, D.A.; Calabrese, V. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front. Biosci., 2007, 1(12), 1107-1123. (Pubitemid 46846882)
14. Brambilla, D.; Mancuso, C.; Scuderi, M.R.; Bosco, P.; Cantarella, G.; Lempereur, L.; Di Benedetto, G.; Pezzino, S.; Bernardini, R. The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile. Nutr. J., 2008, 7, 29.
15. Calabrese, V.; Bates, T.E.; Mancuso, C.; Cornelius, C.; Ventimiglia, B.; Cambria, M.T.; Di Renzo, L.; De Lorenzo, A.; Dinkova-Kostova, A.T. Curcumin and the cellular stress response in free radical-related diseases. Mol. Nutr. Food Res., 2008, 52(9), 1062-1073.
16. Mancuso, C.; Bates, T.E.; Butterfield, D.A.; Calafato, S.; Cornelius, C.; De Lorenzo, A.; Dinkova Kostova, A.T.; Calabrese, V. Natural antioxidants in Alzheimer's disease. Expert. Opin. Investig. Drugs, 2007, 16(12)., 1921-1931.
17. Calabrese, V.; Mancuso, C.; Calvani, M.; Rizzarelli, E.; Butterfield, D.A.; Stella, A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci., 2007, 8(10), 766-775. (Pubitemid 47462116)
18. Li, C.; Hossieny, P.; Wu, B.J.; Qawasmeh, A.; Beck, K.; Stocker, R. Pharmacologic induction of heme oxygenase-1. Antioxid. Redox. Signal., 2007, 9(12), 2227-2239.
19. Takahashi, S.; Wang, J.; Rousseau, D.L.; Ishikawa, K.; Yoshida, T.; Host, J.R.; Ikeda-Saito, M. Heme-heme oxygenase complex. Structure of the catalytic site and its implication for oxygen activation. J. Biol. Chem., 1994, 269(2), 1010-1014. (Pubitemid 24981977)
20. Wilks, A.; Torpey, J.; Ortiz de Montellano, P.R. Heme oxygenase (HO-1). Evidence for electrophilic oxygen addition to the porphyrin ring in the formation of alpha-meso-hydroxyheme. J. Biol. Chem., 1994, 269(47), 29553-29556. (Pubitemid 24365106)
21. Wilks, A.; Ortiz de Montellano, P.R. Rat liver heme oxygenase. High level expression of a truncated soluble form and nature of the meso-hydroxylating species. J. Biol. Chem., 1993, 268(30), 22357-22362. (Pubitemid 23318280)
22. Vreman, H.J.; Ekstrand, B.C.; Stevenson, D.K. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr. Res., 1993, 33(2)., 195-200.
23. Hamori, C.J.; Vreman, H.J.; Rodgers, P.A.; Stevenson, D.K. Zinc protoporphyrin inhibits CO production in rats. J. Pediatr. Gastroenterol. Nutr., 1989, 8(1), 110-115.
24. Posselt, A.M.; Kwong, L.K.; Vreman, H.J.; Stevenson, D.K. Suppression of carbon monoxide excretion rate by tin protoporphyrin. Am. J. Dis. Child., 1986, 140(2), 147-150.
25. Hamori, C.J.; Vreman, H.J.; Stevenson, D.K. Suppression of carbon monoxide excretion by zinc mesoporphyrin in adult Wistar rats: evidence for potent in. vivo inhibition of bilirubin production. Res. Commun. Chem. Pathol. Pharmacol., 1988, 62(1), 41-48.
26. Appleton, S.D.; Chretien, M.L.; McLaughlin, B.E.; Vreman, H.J.; Stevenson, D.K.; Brien, J.F.; Nakatsu, K.; Maurice, D.H.; Marks, G.S. Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations. Drug Metab. Dispos., 1999, 27(10), 1214-1219.
27. Mancuso, C.; Kostoglou-Athanassiou, I.; Forsling, M.L.; Grossman, A.B.; Preziosi, P.; Navarra, P.; Minotti, G. Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypothalamic explants. Molecular linkage between heme catabolism and neuroendocrine function. Brain. Res. Mol. Brain. Res., 1997, 50(1-2), 267-276. (Pubitemid 27488915)
28. Maines, M.D.; Cohn, J. Bile pigment formation by skin heme oxygenase: studies on the response of the enzyme to heme compounds and tissue injury. J. Exp. Med., 1977, 145(4), 1054-1059. (Pubitemid 8092050)
29. Grundemar, L.; Ny, L. Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol. Sci., 1997, 18(6)., 193-195. (Pubitemid 27283648)
30. Vlahakis, J.Z.; Kinobe, R.T.; Bowers, R.J.; Brien, J.F.; Nakatsu, K.; Szarek, W.A. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors. J. Med. Chem., 2006, 49(14), 4437-4441.
31. Mancuso, C. Heme oxygenase and its products in the nervous system. Antioxid. Redox. Signal., 2004, 6, 878-887. (Pubitemid 39237941)
32. Maines, M.D. The heme oxygenase system and its functions in the brain. Cell. Mol. Biol., 2000, 46, 573-585.
33. Sun, J.; Hoshino, H.; Takaku, K.; Nakajima, O.; Muto, A.; Suzuki, H.; Tashiro, S.; Takahashi, S.; Shibahara, S.; Alam, J.; Taketo, M.M.; Yamamoto, M.; Igarashi, K. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J., 2002, 21(19), 5216-5224.
34. Stewart, D.; Killeen, E.; Naquin, R.; Alam, S.; Alam, J. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J. Biol. Chem., 2003, 278(4), 2396-2402. (Pubitemid 36801313)
35. Maines, M.D. The heme oxygenase system: update 2005. Antioxid. Redox. Signal., 2005, 7, 1761-1766.
36. Palozza, P.; Serini, S.; Currò, D.; Calviello, G.; Igarashi, K.; Mancuso, C. Beta-Carotene and cigarette smoke condensate regulate heme oxygenase-1 and its repressor factor Bach1: relationship with cell growth. Antioxid. Redox. Signal., 2006, 8(5-6), 1069-1080. (Pubitemid 44036523)
37. Maines, M.D.; Panahian, N. The heme oxygenase system and cellular defense mechanisms. Do HO-1 and HO-2 have different functions? Adv. Exp. Med. Biol 2001, 502, 249-272 (Pubitemid 34234060)
38. Dwyer, B.E.; Nishimura, R.N.; Lu, S.Y. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res. Mol. Brain Res., 1995, 30, 37-47.
39. Calabrese, V.; Butterfield, D.A.; Scapagnini, G.; Stella, A.M.; Maines, M.D. Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid. Redox. Signal., 2006, 8, 444-477.
40. Calabrese, V.; Sultana, R.; Scapagnini, G.; Guagliano, E.; Sapienza, M.; Bella, R.; Kanski, J.; Pennisi, G.; Mancuso, C.; Stella, A.M.; Butterfield, D.A. Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid. Redox. Signal., 2006, 8., 1975-1986
41. Calabrese, V.; Mancuso, C.; Sapienza, M.; Puleo, E.; Calafato, S.; Cornelius, C.; Finocchiaro, M.; Mangiameli, A.; Di Mauro, M.; Stella, A.M.; Castellino, P. Oxidative stress and cellular stress response in diabetic nephropathy. Cell. Stress. Chaperones., 2007, 12(4), 299-306.
42. Stocker, R.; Glazer, A.N.; Ames, B.N. Antioxidant activity of albumin-bound bilirubin. Proc. Natl. Acad. Sci. USA, 1987, 84, 5918-5922.
43. Minetti, M.; Mallozzi, C.; Di Stasi, A.M.; Pietraforte, D. Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch. Biochem. Biophys., 1998, 352, 165-174. (Pubitemid 28368581)
44. Kapitulnik, J. Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol. Pharmacol., 2004, 66, 773-779.
45. Kapitulnik, J.; Maines, M.D. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends. Pharmacol. Sci., 2009, 30(3), 129-137
46. Maines, M.D. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda, 2005, 20, 382-389.
47. Maines, M.D.; Trakshel, G.M. Purification and characterization of human biliverdin reductase. Arch. Biochem. Biophys., 1993, 300, 320-326.
48. Ewing, J.F.; Weber, C.M.; Maines, M.D. Biliverdin reductase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain. J. Neurochem., 1993, 6, 1015-1023.
49. Maines, M.D.; Ewing, J.F.; Huang, T.J.; Panahian, N. Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. J. Pharmacol. Exp. Ther., 2001, 296, 1091-1097. (Pubitemid 32187386)
50. Ewing, J.F.; Maines, M.D. Immunohistochemical localization of biliverdin reductase in rat brain: age related expression of protein and transcript. Brain Res., 1995, 672, 29-41.
51. Tudor, C.; Lerner-Marmarosh, N.; Engelborghs, Y.; Gibbs, P.E.; Maines, M.D. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin. Biochem. J., 2008, 413(3), 405-416.
52. Lerner-Marmarosh, N.; Shen, J.; Torno, M.D.; Kravets, A.; Hu, Z.; Maines, M.D. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc. Natl. Acad. Sci. USA, 2005, 102(20), 7109-7114. (Pubitemid 40696342)
53. Lerner-Marmarosh, N.; Miralem, T.; Gibbs, P.E.; Maines, M.D. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling. Proc. Natl. Acad. Sci. USA, 2008, 105(19), 6870-6875.
54. Kaide, J.I.; Zhang, F.; Wei, Y.; Jiang, H.; Yu, C.; Wang, W.H.; Balazy, M.; Abraham, N.G.; Nasjletti, A. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J. Clin. Invest., 2001, 107(9), 1163-1171. (Pubitemid 32422913)
55. Zhang, F.; Kaide, J.; Wei, Y.; Jiang, H.; Yu, C.; Balazy, M.; Abraham, N.G.; Wang, W.; Nasjletti, A. Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction. Am. J. Physiol. Heart Circ. Physiol., 2001, 281(1), H350-358. (Pubitemid 32911810)
56. Zhang, F.; Kaide, J.I.; Yang, L.; Jiang, H.; Quan, S.; Kemp, R.; Gong, W.; Balazy, M.; Abraham, N.G.; Nasjletti, A. CO modulates pulmonary vascular response to acute hypoxia: relation to endothelin. Am. J. Physiol. Heart Circ. Physiol., 2004, 286(1), H137-144. (Pubitemid 38049473)
57. Kooli, A.; Kermorvant-Duchemin, E.; Sennlaub, F.; Bossolasco, M.; Hou, X.; Honoré, J.C.; Dennery, P.A.; Sapieha, P.; Varma, D.; Lachapelle, P.; Zhu, T.; Tremblay, S.; Hardy, P.; Jain, K.; Balazy, M.; Chemtob, S. trans-Arachidonic acids induce a heme oxygenase-dependent vasorelaxation of cerebral microvasculature. Free Radic. Biol. Med., 2008, 44(5), 815-825.
58. Rodriguez, F.; Kemp, R.; Balazy, M.; Nasjletti, A. Effects of exogenous heme on renal function: role of heme oxygenase and cyclooxygenase. Hypertension, 2003, 42(4), 680-684. (Pubitemid 37237309)
59. Rodella, L.F.; Vanella, L.; Peterson, S.J.; Drummond, G.; Rezzani, R.; Falck, J.R.; Abraham, N.G. Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes. Drug Metab. Lett., 2008, 2(4), 290-300.
60. Wang, X.M.; Kim, H.P.; Nakahira, K.; Ryter, S.W.; Choi, A.M. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J. Immunol., 2009, 182(6), 3809-3818.
61. Nascimento, C.G.; Branco, L.G. Antinociception synergy between the peripheral and spinal sites of the heme oxygenase-carbon monoxide pathway. Braz. J. Med. Biol. Res., 2009, 42(1), 141-147.
62. Bilban, M.; Haschemi, A.; Wegiel, B.; Chin, B.Y.; Wagner, O.; Otterbein L.E. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J. Mol. Med., 2008, 86(3), 267-279.
63. Sato, K.; Balla, J.; Otterbein, L.; Smith, R.N.; Brouard, S.; Lin, Y.; Csizmadia, E.; Sevigny, J.; Robson, S.C.; Vercellotti, G.; Choi, A.M.; Bach, F.H.; Soares, M.P. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol., 2001, 166(6), ;4185-4194.
64. Mancuso, C.; Tringali, G.; Grossman, A.; Preziosi, P.; Navarra, P. The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin-1beta from the rat hypothalamus in. vitro: evidence for the involvement of different signaling pathways. Endocrinology, 1998, 139, 1031-1037. (Pubitemid 28510120)
65. Navarra P, Dello Russo C, Mancuso C, Preziosi P, Grossman A. Gaseous neuromodulators in the control of neuroendocrine stress axis. Ann. NY Acad. Sci., 2000, 917, 638-646
66. Mancuso, C.; Ragazzoni, E.; Tringali, G.; Liberale, I.; Preziosi, P.; Grossman, A.; Navarra, P. Inhibition of heme oxygenase in the central nervous system potentiates endotoxin-induced vasopressin release in the rat. J. Neuroimmunol., 1999, 99(2), 189-194. (Pubitemid 29518230)
67. Pozzoli, G.; Mancuso, C.; Mirtella, A.; Preziosi, P.; Grossman, A.B.; Navarra, P. Carbon monoxide as a novel neuroendocrine modulator: inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants. Endocrinology, 1994, 135(6), 2314-2317. (Pubitemid 24377382)
68. Steiner, A.A.; Branco, L.G.Carbon monoxide is the heme oxygenase product with a pyretic action: evidence for a cGMP signaling pathway. Am. J. Physiol., 2001, 280, R448-R457. (Pubitemid 32479688)
69. Steiner, A.A.; Branco, L.G. Central CO-heme oxygenase pathway raises body temperature by a prostaglandin-independent way. J. Appl. Physiol., 2000, 88, 1607-1613.
70. Steiner, A.A.; Colombari, E.; Branco, L.G. Carbon monoxide as a novel mediator of the febrile response in the central nervous system. Am. J. Physiol., 1999, 277, R499-R507.
71. Steiner, A.A.; Reste, G.; Branco, L.G. Role of the brain heme oxygenase-carbon monoxide pathway in stress fever in rats. Neurosci. Lett., 2003, 341., 193-196.
72. Ravanelli, M.I.; Almeida, M.C.; Branco, L.G. Role of the locus coeruleus carbon monoxide pathway in endotoxin fever in rats. Pflugers. Arch., 2007, 453(4), 471-476.
73. Coburn, R.F. Endogenous carbon monoxide production. N. Engl. J. Med., 1970, 282(4)., 207-209.
74. Holford, N.H.G. In Basic and Clinical Pharmacology. Bertram, G.K.; Ed.; McGrow-Hill: New York, 2007; pp. 34-49.
75. Piantadosi, C.A. Biological chemistry of carbon monoxide. Antioxid. Redox. Signal., 2002, 4(2), 259-270.
76. Abraham, N.G.; Jiang, H.; Balazy, M.; Goodman, A.I. Methods for measurements of heme oxygenase (HO) isoforms-mediated synthesis of carbon monoxide and HO-1 and HO-2 proteins. Methods Mol. Med., 2003, 86, 399-411.
77. Marks, G.S.; Vreman, H.J.; McLaughlin, B.E.; Brien, J.F.; Nakatsu, K. Measurement of endogenous carbon monoxide formation in biological systems. Antioxid. Redox. Signal., 2002, 4(2), 271-277. (Pubitemid 34517178)
78. Bathoorn, E.; Slebos, D.J.; Postma, D.S.; Koeter, G.H.; van Oosterhout, A.J.; van der Toorn, M.; Boezen, H.M.; Kerstjens, H.A. Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur. Respir. J., 2007, 30(6), 1131-1137.
79. Haschemi, A.; Wagner, O.; Marculescu, R.; Wegiel, B.; Robson, S.C.; Gagliani, N.; Gallo, D.; Chen, J.F.; Bach, F.H.; Otterbein, L.E. Cross-regulation of carbon monoxide and the adenosine A2a receptor in macrophages. J. Immunol., 2007, 178(9), 5921-5929.
80. Otterbein, L.E.; Bach, F.H.; Alam, J.; Soares, M.; Tao Lu, H.; Wysk, M.; Davis, R.J.; Flavell, R.A.; Choi, A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med., 2000, 6(4), 422-428.
81. Thom, S.R.; Fisher, D.; Xu, Y.A.; Notarfrancesco, K.; Ischiropoulos, H. Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc. Natl. Acad. Sci. USA, 2000, 97(3), 1305-1310. (Pubitemid 30080854)
82. Thom, S.R.; Fisher, D.; Xu, Y.A.; Garner, S.; Ischiropoulos, H. Role of nitric oxide-derived oxidants in vascular injury from carbon monoxide in the rat. Am. J. Physiol., 1999, 276(3 Pt 2), H984-992. (Pubitemid 29157472)
83. Thom, S.R.; Ohnishi, S.T.; Fisher, D.; Xu, Y.A.; Ischiropoulos, H. Pulmonary vascular stress from carbon monoxide. Toxicol. Appl. Pharmacol., 1999, 154(1), 12-19. (Pubitemid 29042595)
84. Thom, S.R.; Kang, M.; Fisher, D.; Ischiropoulos, H. Release of glutathione from erythrocytes and other markers of oxidative stress in carbon monoxide poisoning. J. Appl. Physiol., 1997, 82(5), 1424-1432. (Pubitemid 27203848)
85. Motterlini, R.; Clark, J.E.; Foresti, R.; Sarathchandra, P.; Mann, B.E.; Green, C.J. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ. Res., 2002, 90(2), E17-24.
86. Clark, J.E.; Naughton, P.; Shurey, S.; Green, C.J.; Johnson, T.R.; Mann, B.E.; Foresti, R.; Motterlini, R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ. Res., 2003, 93(2), e2-8.
87. Motterlini, R.; Sawle, P.; Hammad, J.; Bains, S.; Alberto, R.; Foresti, R.; Green, C.J. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J, 2005., 19(2), 284-286. (Pubitemid 40189283)
88. Basuroy, S.; Bhattacharya, S.; Leffler, C.W.; Parfenova, H. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. Am. J. Physiol. Cell. Physiol., 2009, 296(3), C422-432.
89. Brown, S.D.; Piantadosi, C.A. Recovery of energy metabolism in rat brain after carbon monoxide hypoxia.. J. Clin. Invest., 1992, 89, 666-672
90. Zhang, J.; Piantadosi, C.A. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain.. J. Clin. Invest., 1992, 90, 1193-1199
91. Sandouka, A.; Balogun, E.; Foresti, R.; Mann, B.E.; Johnson, T.R.; Tayem, Y.; Green, C.J.; Fuller, B.; Motterlini, R. Carbon monoxide-releasing molecules (CO-RMs) modulate respiration in isolated mitochondria. Cell. Mol. Biol. (Noisy-le-grand), 2005, 51, 425-432. (Pubitemid 41596320)
92. Taille, C.; El-Benna, J.; Lanone, S.; Boczkowski, J.; Motterlini, R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J. Biol. Chem., 2005, 280, 25350-25360. (Pubitemid 40962237)
93. Sawle, P.; Foresti, R.; Mann, B.E.; Johnson, T.R.; Green, C.J.; Motterlini R. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br. J. Pharmacol, 2005, 145, 800-810. (Pubitemid 41076287)
94. Utz, J.; Ullrich, V. Carbon monoxide relaxes ileal smooth muscle through activation of guanylate cyclase. Biochem. Pharmacol., 1991, 41(8):1195-1201
95. Brüne, B.; Schmidt, K.U.; Ullrich, V. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur. J. Biochem., 1990., 192(3):683-688 (Pubitemid 20316870)
96. Ma, X.; Sayed, N.; Beuve, A.; van den Akker, F. NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism. EMBO J., 2007, 26(2), 578-588.
97. Burstyn, J.N.; Yu, A.E.; Dierks, E.A.; Hawkins, B.K.; Dawson, J.H. Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme. Biochemistry, 1995, 34(17), 5896-5903.
98. Kharitonov, V.G.; Sharma, V.S.; Pilz, R.B.; Magde, D.; Koesling, D. Basis of guanylate cyclase activation by carbon monoxide. Proc. Natl. Acad. Sci. USA, 1995, 92(7), 2568-2571.
99. Burgunder, J.M.; Cheung, P.T. Expression of soluble guanylyl cyclase gene in adult rat brain. Eur. J. Neurosci., 1994, 6(2), 211-217. (Pubitemid 24050722)
100. Matsuoka, I.; Giuili, G.; Poyard, M.; Stengel, D.; Parma, J.; Guellaen, G.; Hanoune, J. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci., 1992, 12(9), 3350-3360.
101. Coceani, F.; Kelsey, L.; Seidlitz, E. Carbon monoxide-induced relaxation of the ductus arteriosus in the lamb: evidence against the prime role of guanylyl cyclase. Br. J. Pharmacol., 1996, 118: 1689-1696. (Pubitemid 26252663)
102. Mancuso, C.; Pistritto, G.; Tringali, G.; Grossman, A.B.; Preziosi, P.; Navarra P. Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypothalamic explants and in primary cultures of rat hypothalamic astrocytes. Brain Res. Mol. Brain Res., 1997, 45, 294-300. (Pubitemid 27170706)
103. Mancuso, C.; Perluigi, M.; Cini, C.; De Marco, C.; Giuffrida Stella, A.M.; Calabrese V. Heme oxygenase and cyclooxygenase in the central nervous system: a functional interplay. J. Neurosci. Res., 2006, 84(7), 1385-1391. (Pubitemid 44687398)
104. Doré, S.; Takahashi, M.; Ferris, C.D.; Zakhary, R.; Hester, L.D.; Guastella, D.; Snyder, S.H. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. USA, 1999, 96, 2445-2450. (Pubitemid 29117935)
105. Takahashi, M.; Doré, S.; Ferris, C.D.; Tomita, T.; Sawa, A.; Wolosker, H.; Borchelt, D.R.; Iwatsubo, T.; Kim, S.H.; Thinakaran, G.; Sisodia, S.S.; Snyder, S.H. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron, 2000, 28, 461-473.
106. Baranano, D.E.; Rao, M.; Ferris, C.D,; Snyder, S.H. Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. USA, 2002, 99, 16093-16098.
107. Dennery, P.A.; Seidman, D.S.; Stevenson, D.K. Neonatal hyperbilirubinemia. N. Engl. J. Med., 2001, 344, 581-590.
108. Rodrigues, C.M.; Sola, S.; Castro, R.E.; Laires, P.A.; Brites, D.; Moura, J.J. Perturbation of membrane dynamics in nerve cells as an early event during bilirubin-induced apoptosis. J. Lipid. Res., 2002, 43, 885-894.
109. Rodrigues, C.M., Sola, S., and Brites, D. Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology, 2002, 35, 1186-1195. (Pubitemid 34454016)
110. Brito, M.A., Brites, D., and Butterfield, D.A. A link between hyperbilirubinemia, oxidative stress and injury to neocortical synaptosomes. Brain Res., 2004, 1026, 33-43. (Pubitemid 39336414)
111. Barone, E.; Trombino, S.; Cassano, R.; Sgambato, A.; De Paola, B.; Di Stasio, E.; Picci, N.; Preziosi, P.; Mancuso, C. Characterization of the S-denitrosylating activity of bilirubin. J. Cell Mol. Med., 2009 Jan 28.
112. Ponka, P. Rare causes of hereditary iron overload. Semin. Hematol., 2002, 39, 249-262. (Pubitemid 35192638)
113. Chiueh, CC. Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr. Neurol., 2001, 25, 138-147. (Pubitemid 32830163)
114. Goldstein, L.; Teng, Z.P.; Zeserson, E.; Patel, M.; Regan, R.F. Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J. Neurosci. Res., 2003, 73, 113-121.
115. Van Bergen, P.; Rauhala, P.; Spooner, C.M.; Chiueh, C.C. Hemoglobin and iron-evoked oxidative stress in the brain: protection by bile pigments, manganese and S-nitrosoglutathione. Free Radic. Res., 1999, 31, 631-640.
116. Schipper, H.M. Heme oxygenase-1: role in brain aging and neurodegeneration. Exp. Gerontol., 2000, 35, 821-830. (Pubitemid 30798080)
117. Panahian, N.; Yoshiura, M.; Maines, M.D. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J. Neurochem., 1999, 72, 1187-1203.
118. Takeda, A.; Perry, G.; Abraham, N.G.; Dwyer, B.E.; Kutty, R.K.; Laitinen, J.T.; Petersen, R.B.; Smith, M.A. Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J. Biol. Chem., 2000, 275, 5395-5399.
119. Koeppen, A.H.; Dickson, A.C. Neuroprotection in intracerebral hemorrhage with tin-protoporphyrin. Ann. Neurol., 1999, 46, 938.
120. Schipper, H.M.; Bernier, L.; Mehindate, K.; Frankel, D. Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore. J. Neurochem., 1999, 72, 1802-1811. (Pubitemid 29185982)
121. Gutstein, H.B.; Akil, H. In Goodman & Gilman's. The Pharmacological Basis of Therapeutics; Laurence L.B.; Ed.; McGrow-Hill: New York, 2006; pp. 547-590.
122. Li, X.; Clark, J.D. Heme oxygenase inhibitors reduce formalin-induced Fos expression in mouse spinal cord tissue. Neuroscience, 2001, 105(4), 949-956.
123. Li, X.; Clark, D.J. Chronic morphine exposure and the expression of heme oxygenase type 2. Brain Res. Mol. Brain Res., 2000, 75(2), 179-184.
124. Liang, D.; Li, X.; Lighthall, G.; Clark, J.D. Heme oxygenase type 2 modulates behavioral and molecular changes during chronic exposure to morphine. Neuroscience, 2003, 121(4), 999-1005.
125. Li, X.; Angst, M.S.; Clark, J.D. A murine model of opioid-induced hyperalgesia. Brain Res. Mol. Brain Res., 2001, 86(1-2), 56-62.
126. Rabbani, M.; Hajhashemi, V.; Mesripour, A. Increase in brain corticosterone concentration and recognition memory impairment following morphine withdrawal in mice. Stress, 2009, 10, 1.
127. Núñez, C.; Földes, A.; Pérez-Flores, D.; García-Borrón, J.C.; Laorden, M.L.; Kovács, K.J.; Milanés, M.V. Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal. Endocrinology, 2009, 150(7), 3118-3127.
128. Bhat, R.S; Bhaskaran, M.; Mongia, A.; Hitosugi, N.; Singhal, P.C. Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J. Leukoc. Biol., 2004, 75(6), 1131-1138.
129. Patel, K.; Bhaskaran, M.; Dani, D.; Reddy, K.; Singhal, P.C. Role of heme oxygenase-1 in morphine-modulated apoptosis and migration of macrophages. J. Infect. Dis., 2003, 187(1), 47-54.
130. Patel, J.; Manjappa, N.; Bhat, R.; Mehrotra, P.; Bhaskaran, M.; Singhal, P.C. Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth. Am. J. Physiol. Renal. Physiol., 2003, 285(5), F861-869.
131. Raju, V.S.; McCoubrey, W.K. Jr; Maines, M.D. Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim. Biophys. Acta, 1997, 1351(1-2), 89-104.
132. Liu. N.; Wang, X.; McCoubrey, W.K.; Maines, M.D. Developmentally regulated expression of two transcripts for heme oxygenase-2 with a first exon unique to rat testis: control by corticosterone of the oxygenase protein expression. Gene, 2000, 241(1), 175-183.
133. Ewing, J.F.; Maines, M.D. Histochemical localization of heme oxygenase-2 protein and mRNA expression in rat brain. Brain Res. Brain Res. Protoc., 1997, 1(2), 165-174. (Pubitemid 28281340)
134. Maines, M.D.; Eke, B.C.; Weber, C.M.; Ewing, J.F. Corticosterone has a permissive effect on expression of heme oxygenase-1 in CA1-CA3 neurons of hippocampus in thermal-stressed rats. J. Neurochem., 1995, 64(4), 1769-1779.
135. Schröder, H. Nitric oxide and aspirin: a new mediator for an old drug. Am. J. Ther., 2008 Dec 15.
136. Grosser, N.; Abate, A.; Oberle, S.; Vreman, H.J.; Dennery, P.A.; Becker, J.C.; Pohle, T.; Seidman, D.S.; Schröder, H. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem. Biophys. Res. Commun., 2003, 308(4), 956-960. (Pubitemid 36976552)
137. Horváth, K.; Varga, C.; Berkó, A.; Pósa, A.; László, F.; Whittle, B.J. The involvement of heme oxygenase-1 activity in the therapeutic actions of 5-aminosalicylic acid in rat colitis. Eur. J. Pharmacol., 2008, 581(3), 315-323.
138. Cantoni, L.; Valaperta, R.; Ponsoda, X.; Castell, J.V.; Barelli, D.; Rizzardini, M.; Mangolini, A.; Hauri, L.; Villa, P. Induction of hepatic heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity. J. Hepatol., 2003, 38(6), 776-783 (Pubitemid 36613344)
139. Hou, C.C.; Hung, S.L.; Kao, S.H.; Chen, T.H.; Lee, H.M. Celecoxib induces heme-oxygenase expression in glomerular mesangial cells. Ann. NY. Acad. Sci., 2005, 1042, 235-245. (Pubitemid 40967644)
140. Moen, M.D.; McKeage, K.; Plosker, G.L.; Siddiqui, M.A. Imatinib: a review of its use in chronic myeloid leukaemia. Drugs, 2007, 67(2), 299-320. (Pubitemid 46259331)
141. Hochhaus, A. First-Line management of CML: a state of the art review. J. Natl. Compr. Canc. Netw., 2008, 6(Suppl 2), S1-S10. (Pubitemid 351871429)
142. Nagai, T.; Kikuchi, S.; Ohmine, K.; Miyoshi, T.; Nakamura, M.; Kondo, T.; Furuyama, K.; Komatsu, N.; Ozawa, K. Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2. J. Cell. Biochem., 2008, 104(2), 680-691. (Pubitemid 351671654)
143. Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev., 2004, 56(2), 185-229.
144. Wissel, P.S.; Drummond, G.S.; Kappas, A. Protective effect of Sn-protoporphyrin against doxorubicin-induced perturbations of heme metabolism. Life. Sci., 1990, 47(17), 1595-1599.
145. Suliman, H.B.; Carraway, M.S.; Ali, A.S.; Reynolds, C.M.; Welty-Wolf, K.E.; Piantadosi, C.A. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J. Clin. Invest., 2007, 117(12), 3730-3741.
146. Wolf, S.C.; Sauter, G.; Jobst, J.; Kempf, V.A.; Risler, T.; Brehm, B.R. Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment. Int. J. Cardiol., 2008, 125(1), 4-10. (Pubitemid 351305421)
147. Tanaka, S.; Yamagishi, R.; Tsutsui, M.; Kishida, T.; Murakami, M.; Kuroda, J.; Yoshida, T. Tissue- and dose-dependent alteration of stress-inducible proteins by beta2-adrenoceptor agonist, salbutamol, in rats. J. Toxicol. Sci., 2005, 30(4), 305-314.
148. Raddatz, A.; Kubulus, D.; Winning, J.; Bauer, I.; Pradarutti, S.; Wolf, B.; Kreuer, S.; Rensing, H. Dobutamine improves liver function after hemorrhagic shock through induction of heme oxygenase-1. Am. J. Respir. Crit. Care. Med., 2006, 174(2), 198-207. (Pubitemid 44015393)
149. Rensing, H.; Bauer, I.; Kubulus, D.; Wolf, B.; Winning, J.; Ziegeler, S.; Bauer, M. Heme oxygenase-1 gene expression in pericentral hepatocytes through beta1-adrenoceptor stimulation. Shock, 2004, 21(4), 376-387.
150. Ishizaka, N.; De León, H.; Laursen, J.B.; Fukui, T.; Wilcox, J.N.; De Keulenaer, G.; Griendling, K.K.; Alexander, R.W. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation, 1997, 96(6)., 1923-1929. (Pubitemid 27400754)
151. Lo, W.C.; Chan, J.Y.; Tung, C.S.; Tseng, C.J. Carbon monoxide and metabotropic glutamate receptors in rat nucleus tractus solitarii: participation in cardiovascular effect. Eur. J. Pharmacol., 2002, 454(1), 39-45.
152. Lo, W.C.; Jan, C.R.; Chiang, H.T.; Tseng, C.J. Modulatory effects of carbon monoxide on baroreflex activation in nucleus tractus solitarii of rats. Hypertension, 2000, 35(6), 1253-1257.
153. Kubulus, D.; Mathes, A.; Pradarutti, S.; Raddatz, A.; Heiser, J.; Pavlidis, D.; Wolf, B.; Bauer, I.; Rensing, H. Hemin arginate-induced heme oxygenase 1 expression improves liver microcirculation and mediates an anti-inflammatory cytokine response after hemorrhagic shock. Shock, 2008, 29(5), 583-590. (Pubitemid 351544078)
154. So, H.S.; Kim, H.J.; Lee, J.H.; Lee, J.H.; Park, S.Y.; Park, C.; Kim, Y.H.; Kim, J.K.; Lee, K.M.; Kim, K.S.; Chung, S.Y.; Jang, W.C.; Moon, S.K.; Chung, H.T.; Park, R.K. Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin. Cell. Death Differ., 2006, 13(10), 1763-1775.
155. Koleva, M.; Stoytchev, T. On the enzyme-inducing action of calcium antagonists. Arch. Toxicol., 1993, 67(4), 294-296.
156. Izuhara, Y.; Nangaku, M.; Inagi, R.; Tominaga, N.; Aizawa, T.; Kurokawa, K.; Van Ypersele de Strihou, C.; Miyata, T. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J. Am. Soc. Nephrol., 2005, 16(12), 3631-3641. (Pubitemid 46211284)
157. Ishizaka, N.; Aizawa, T.; Mori, I.; Taguchi, J.; Yazaki, Y.; Nagai, R.; Ohno, M. Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am. J. Physiol. Heart Circ. Physiol., 2000, 279(2), H672-H678. (Pubitemid 30672779)
158. Ishizaka, N.; Saito, K.; Mitani, H.; Yamazaki, I.; Sata, M.; Usui, S.; Mori, I.; Ohno, M.; Nagai, R. Iron overload augments angiotensin II-induced cardiac fibrosis and promotes neointima formation. Circulation, 2002, 106(14), 1840-1846.
159. Palardy, M.; Ducharme, A.; O'Meara, E. Inhibiting the reninangiotensin system with ACE Inhibitors or ARBs after MI. Curr. Heart Fail Rep., 2007, 4(4)., 190-197.
160. Duprez, D.A. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J. Hypertens, 2006, 24(6), 983-991.
161. Michel, T. In Goodman and Gilman' The Pharmacological Basis of Therapeutics, 11th ed. Laurence L.B.; Ed.; McGraw-Hill, New York, 2006; pp. 823-844.
162. Chen, Z.; Zhang, J.; Stamler, J.S. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc. Natl. Acad. Sci. USA, 2002, 99(12), 8306-8311.
163. Oberle, S.; Abate, A.; Grosser, N.; Hemmerle, A.; Vreman, H.J.; Dennery, P.A.; Schneider, H.T.; Stalleicken, D.; Schröder, H. Endothelial protection by pentaerithrityl trinitrate: bilirubin and carbon monoxide as possible mediators. Exp. Biol. Med., 2003, 228(5), 529-534. (Pubitemid 37203672)
164. Malloy, M.J.; Kane, J.P. In Basic and Clinical Pharmacology, Bertram G. Katzung, Ed.; McGrow-Hill-Lange: New York, 2007; pp. 560-572.
165. Lai, I.R.; Chang, K.J.; Tsai, H.W.; Chen, C.F. Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction. Transplantation, 2008, 85(5), 732-738.
166. Hsu, M.; Muchova, L.; Morioka, I.; Wong, R.J.; Schröder, H.; Stevenson, D.K. Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem. Biophys. Res. Commun., 2006, 343(3), 738-744.
167. Hsieh, C.H.; Rau, C.S.; Hsieh, M.W.; Chen, Y.C.; Jeng, S.F.; Lu, T.H.; Chen, S.S. Simvastatin-induced heme oxygenase-1 increases apoptosis of Neuro 2A cells in response to glucose deprivation. Toxicol. Sci., 2008, 101(1), 112-121.
168. Gagov, H.; Kadinov, B.; Hristov, K.; Boev, K.; Itzev, D.; Bolton, T.; Duridanova, D. Role of constitutively expressed heme oxygenase-2 in the regulation of guinea pig coronary artery tone. Pflugers. Arch, 2003, 446(4), 412-421. (Pubitemid 36920933)
169. Pannen, B.H.; Bauer, M. Differential regulation of hepatic arterial and portal venous vascular resistance by nitric oxide and carbon monoxide in rats. Life Sci., 1998, 62(22)., 2025-2033. (Pubitemid 28239715)
170. Schwertner, H.A.; Vítek, L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis, 2008, 198(1), 1-11.
171. Vítek, L.; Novotný, L.; Sperl, M.; Holaj, R.; Spácil, J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc. Dis., 2006, 21(5-6), 408-414. (Pubitemid 44617309)
172. Potter, W.Z.; Hollister, L.E. In Basic and Clinical Pharmacology; Bertram G.K.; Ed.; McGrow-Hill-Lange: New York, 2007; pp. 475-488.
173. Chen, Z.; Xu, H.; Haimano, S.; Li, X.; Li, XM. Quetiapine and venlafaxine synergically regulate heme oxygenase-2 protein expression in the hippocampus of stressed rats. Neurosci. Lett., 2005, 389(3), 173-177.
174. Senda, N.; Hoshi, K.; Fujino, S. Effects of perphenazine, chlorpromazine or CoCl2 on the activities of delta-aminolevulinic acid synthetase and heme oxygenase and on the content of hemoprotein in rat liver. Res. Commun. Chem. Pathol. Pharmacol., 1989, 65(1), 57-64. (Pubitemid 19205762)
175. Gonçalves, G.M.; Cenedeze, M.A.; Feitoza, C.Q.; De Paula, C.B.; Macusso, G.D.; Pinheiro, H.S.; Teixeira Vde, P.; Dos Reis, M.A.; Pacheco-Silva, A.; Câmara, N.O. Heme oxygenase 1 and renal ischemia and reperfusion injury: the impact of immunosuppressive drug. Int. Immunopharmacol., 2006, 6(13-14), 1966-1972.
176. Rezzani, R.; Rodella, L.; Bianchi, R.; Goodman, A.I.; Lianos, E.A. Protective effects of heme-oxygenase expression in cyclosporine A - induced injury. Curr. Neurovasc. Res., 2005, 2(2), 157-161.
177. Soares, M.P.; Lin, Y.; Anrather, J.; Csizmadia, E.; Takigami, K.; Sato, K.; Grey, S.T.; Colvin, R.B.; Choi, A.M.; Poss, K.D.; Bach, F.H. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med., 1998, 4(9), 1073-1077.
178. Feitoza, C.Q.; Gonçalves, G.M.; Bertocchi, A.P.; Wang, P.W.; Damião, M.J.; Cenedeze, M.A.; Teixeira, V.P.; Dos Reis, M.A.; Pacheco-Silva, A.; Câmara, N.O. A role for HO-1 in renal function impairment in animals subjected to ischemic and reperfusion injury and treated with immunosuppressive drugs. Transplant. Proc., 2007, 39(2), 424-426.
179. Gonçalves, G.M.; Cenedeze, M.A.; Feitoza, C.Q.; Wang, P.M.; Bertocchi, A.P.; Damião, M.J.; Pinheiro, H.S.; Antunes Teixeira, V.P.; Dos Reis, M.A.; Pacheco-Silva, A.; Câmara, N.O. The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int., 2006, 70(10), 1742-1749. (Pubitemid 44684805)
180. Zhou, H.; Liu, H.; Porvasnik, S.L.; Terada, N.; Agarwal, A.; Cheng, Y.; Visner, G.A. Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension. Lab. Invest., 2006, 86(1), 62-71. (Pubitemid 43250969)
181. Sato, K.; Balla, J.; Otterbein, L.; Smith, R.N.; Brouard, S.; Lin, Y.; Csizmadia, E.; Sevigny, J.; Robson, S.C.; Vercellotti, G.; Choi, A.M.; Bach, F.H.; Soares, M.P. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol., 2001, 166(6), 4185-4194.
182. Kondo, N.; Fukutomi, O.; Kameyama, T.; Orii, T. Inhibition of proliferative responses of lymphocytes to food antigens by an antiallergic drug, N(3',4'-dimethoxycinnamoyl) anthranilic acid (Tranilast) in children with atopic dermatitis. Clin. Exp. Allergy, 1992, 22(4), 447-453.
183. Ukai, K.; Masuda, S.; Shinoki, J.; Sakakura, Y. Clinical and pathophysiological evaluation of tranilast in patients with pollinosis: the effects of pre-seasonal treatment. Auris. Nasus. Larynx., 1993., 20(4), 275-284.
184. Holmes, D.R. Jr.; Savage, M.; LaBlanche, J.M.; Grip, L.; Serruys, P.W.; Fitzgerald, P.; Fischman, D.; Goldberg, S.; Brinker, J.A.; Zeiher, A.M.; Shapiro, L.M.; Willerson, J.; Davis, B.R.; Ferguson, J.J.; Popma, J.; King, S.B. 3rd.; Lincoff, A.M.; Tcheng, J.E.; Chan, R.; Granett, J.R.; Poland, M. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation, 2002, 106(10), 1243-1250.
185. Pae, H.O.; Jeong, S.O.; Koo, B.S.; Ha, H.Y.; Lee, K.M.; Chung, H.T. Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but downregulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages. Biochem. Biophys. Res. Commun., 2008, 371(3), 361-365.
186. Behling, A.; Rohde, L.E.; Colombo, F.C.; Goldraich, L.A.; Stein, R.; Clausell, N. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. J. Card. Fail., 2008, 14(3), 189-197.
187. Lewis, G.D.; Shah, R.; Shahzad, K.; Camuso, J.M.; Pappagianopoulos, P.P.; Hung, J.; Tawakol, A.; Gerszten, R.E.; Systrom, D.M.; Bloch, K.D.; Semigran, M.J. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation, 2007, 116(14), 1555-1562. (Pubitemid 47511419)
188. Lewis, G.D.; Lachmann, J.; Camuso, J.; Lepore, J.J.; Shin, J.; Martinovic, M.E.; Systrom, D.M.; Bloch, K.D.; Semigran, M.J. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation, 2007, 115(1), 59-66. (Pubitemid 46058612)
189. Aziz, M.T.; Mostafa, T.; Atta, H.; Rashed, L.; Marzouk, S.A.; Obaia, E.M.; Sabry, D.; Hassouna, A.A.; El-Shehaby, A.M.; Aziz, A.T.; The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues. J. Sex. Med., 2008, 5(7), 1636-1645.
190. Aziz, M.T.; Al-Asmar, M.F.; Mostafa, T.; Atta, H.; Rashed, L.; Sabry, D.; Ashour, S.; Aziz, A.T. Assessment of heme oxygenase-1 (HO-1) activity in the cavernous tissues of sildenafil citrate-treated rats. Asian J. Androl., 2007, 9(3), 377-381.
191. Rahman, I.; Biswas, S.K.; Kirkham, P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol., 2006, 72(11), 1439-1452. (Pubitemid 44666744)
192. Tirkey, N.; Kaur, G.; Vij, G.; Chopra, K.; Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC. Pharmacol., 2005, 5, 15.
193. Chen, J.; Tang, X.Q.; Zhi, J.L.; Cui, Y.; Yu, H.M.; Tang, E.H.; Sun, S.N.; Feng, J.Q.; Chen, P.X. Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl- 2-mitochondria-ROS- iNOS pathway. Apoptosis, 2006, 11(6), 943-953.
194. Divya, C.S.; Pillai, M.R. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol. Carcinog., 2006, 45(5), 320-332.
195. Perez-Arriaga, L.; Mendoza-Magana, M.L.; Cortes-Zarate, R.; Corona-Rivera, A.; Bobadilla-Morales, L.; Troyo-Sanroman, R.; Ramirez-Herrera, M.A. Cytotoxic effect of curcumin on Giardia lamblia trophozoites. Acta Trop., 2006, 98(2), 152-161. (Pubitemid 43783139)
196. Ramsewak, R.S.; DeWitt, D.L.; Nair, M.G. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine, 2000, 7(4), 303-308.
197. Mehta, K.; Pantazis, P.; McQueen, T.; Aggarwal, B.B. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs, 1997, 8(5), 470-481.
198. Abuarqoub, H.; Green, C.J.; Foresti, R.; Motterlini, R. Curcumin reduces cold storage-induced damage in human cardiac myoblasts. Exp. Mol. Med., 2007, 39, 139-148. (Pubitemid 46683399)
199. Jeong, G.S.; Oh, G.S.; Pae, H.O.; Jeong, S.O.; Kim, Y.C.; Shin, M.K.; Seo, B.Y.; Han, S.Y., Lee, H.S.; Jeong J.G.; Koh, J.S.; Chung, H.T. Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection. Exp. Mol. Med., 2006, 38, 393-400. (Pubitemid 44351434)
200. McNally, S.J.; Harrison, E.M.; Ross, J.A.; Garden, O.J.; Wigmore, S.J. Curcumin induces heme oxygenase-1 in hepatocytes and is protective in simulated cold preservation and warm reperfusion injury. Transplantation, 2006, 81, 623-626.
201. Rushworth, S.A.; Ogborne, R.M.; Charalambos, C.A.; O'Connell, M.A. Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. Biochem. Biophys. Res. Commun., 2006, 341, 1007-1016.
202. Scapagnini, G.; Colombrita, C.; Amadio, M.; D'Agata, V.; Arcelli, E.; Sapienza, M.; Quattrone, A.; Calabrese, V. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid. Redox. Signal., 2006, 8, 395-403. (Pubitemid 43741311)
203. Balogun, E.; Foresti, R.; Green, C.J.; Motterlini, R. Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells. Biochem. Biophys. Res. Commun., 2003, 308, 950-955. (Pubitemid 36976551)
204. McNally, S.J.; Harrison, E.M.; Ross, J.A.; Garden, O.J.; Wigmore, S.J. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int. J. Mol. Med., 2007., 19, 165-172.
205. Andreadi, C.K.; Howells, L.M.; Atherfold, P.A.; Manson, M.M. Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol. Pharmacol., 2006, 69, 1033-1040.
206. Wenzel, E.; Somoza, V. Metabolism and bioavailability of transresveratrol. Mol. Nutr. Food Res., 2005, 49(5), 472-481.
207. Gescher, A.J.; Steward, W.P. Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol. Biomarkers Prev., 2003, 12(10), 953-957.
208. Baur, J.A.; Sinclair, D.A. Therapeutic potential of resveratrol: the in. vivo evidence. Nat. Rev. Drug Discov., 2006, 5(6), 493-506.
209. Chen, C.Y.; Jang, J.H.; Li, M.H.; Surh, Y.J. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem. Biophys. Res. Commun., 2005, 331(4), 993-1000.
210. Zhuang, H.; Kim, Y.S.; Koehler, R.C.; Dore, S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann. NY Acad. Sci., 2003, 993, 276-286. (Pubitemid 36808455)
211. D'Archivio, M.; Filesi, C.; Di Benedetto, R.; Gargiulo, R.; Giovannini, C.; Masella, R. Polyphenols, dietary sources and bioavailability. Ann. Ist Super Sanita., 2007, 43, 348-361.
212. Rechner, A.R.; Spencer, J.P.; Kuhnle, G.; Hahn, U., Rice-Evans, C.A. Novel biomarkers of the metabolism of caffeic acid derivatives in. vivo. Free. Radic. Biol. Med., 2001, 30, 1213-1222. (Pubitemid 32463932)
213. Saulnier, L.; Vigouroux, J.; Thibault, J.F. Isolation and partial characterization of feruloylated oligosaccharides from maize bran. Carbohydr. Res., 1995, 272, 241-253.
214. Calabrese, V.; Calafato, S.; Puleo, E.; Cornelius, C.; Sapienza, M.; Morganti, P.; Mancuso, C. Redox regulation of cellular stress response by ferulic acid ethyl ester in human dermal fibroblast: role of vitagenes. Clin. Dermatol., 2008.
215. Joshi, G.; Perluigi, M.; Sultana, R.; Agrippino, R.; Calabrese, V.; Butterfield, D.A. In. vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane) dihydrochloride (AAPH) or Fe(2+)/H(2) O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders. Neurochem. Int., 2006, 48(4), 318-327.
216. Scapagnini, G.; Butterfield, D.A.; Colombrita, C.; Sultana, R.; Pascale, A.; Calabrese, V. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid. Redox. Signal., 2004, 6, 811-818. (Pubitemid 39237933)
217. Kanski, J.; Aksenova, M.; Stoyanova, A.; Butterfield, D.A. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in. vitro: structure-activity studies. J. Nutr. Biochem., 2002, 13, 273-281.
218. Barone, E.; Calabrese, V.; Mancuso, C. Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology, 2009, 10(2), 97-108.
219. Evans, A.M.; Fornasini, G. Pharmacokinetics of L-carnitine. Clin. Pharmacokinet., 2003, 42(11), 941-967.
220. McDaniel, M.A.; Maier, S.F.; Einstein, G.O. "Brain-specific" nutrients: a memory cure? Nutrition, 2003., 19(11-12), 957-975.
221. Abdul, H.M.; Calabrese, V.; Calvani, M.; Butterfield, D.A. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J. Neurosci. Res., 2006, 84(2), 398-408.
222. Calabrese, V.; Colombrita, C.; Sultana, R.; Scapagnini, G.; Calvani, M.; Butterfield, D.A.; Stella A.M. Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: relationship to antioxidant status and mitochondrial function. Antioxid. Redox. Signal., 2006, 8(3-4), 404-416.
223. Baum, L.; Lam, C.W.; Cheung, S.K.; Kwok, T.; Lui, V.; Tsoh, J.; Lam, L.; Leung, V.; Hui, E.; Ng, C.; Woo, J.; Chiu, H.F.; Goggins, W.B.; Zee, B.C.; Cheng, K.F.; Fong, C.Y.; Wong, A.; Mok, H.; Chow, M.S.; Ho, P.C.; Ip, S.P.; Ho, C.S.; Yu, X.W.; Lai, C.Y.; Chan, M.H.; Szeto, S.; Chan, I.H.; Mok, V. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol., 2008, 28(1), 110-113.
224. Baum, L.; Cheung, S.K., Mok, V.C.; Lam, L.C.; Leung, V.P.; Hui, E.; Ng, C.C.; Chow, M.; Ho, P.C.; Lam, S.; Woo, J.; Chiu, H.F.; Goggins, W.; Zee, B.; Wong, A.; Mok, H.; Cheng, W.K.; Fong, C.; Lee, J.S.; Chan, M.H.; Szeto, S.S.; Lui, V.W.; Tsoh, J.; Kwok, T.C.; Chan, I.H.; Lam, C.W. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol. Res., 2007, 56(6), 509-514.
225. Chainani-Wu, N.; Silverman, S. Jr.; Reingold, A.; Bostrom, A.; Mc Culloch, C.; Lozada-Nur, F.; Weintraub, J. A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus. Phytomedicine, 2007, 14(7-8), 437-446. (Pubitemid 47068956)
226. Hanai, H.; Iida, T.; Takeuchi, K.; Watanabe, F.; Maruyama, Y.; Andoh, A.; Tsujikawa, T.; Fujiyama, Y.; Mitsuyama, K.; Sata, M.; Yamada, M.; Iwaoka, Y.; Kanke, K.; Hiraishi, H.; Hirayama, K.; Arai, H.; Yoshii, S.; Uchijima, M.; Nagata, T.; Koide, Y. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin. Gastroenterol. Hepatol., 2006, 4(12), 1502-1506. (Pubitemid 44880023)
227. Spaak, J.; Merlocco, A.C.; Soleas, G.J.; Tomlinson, G.; Morris, B.L.; Picton, P.; Notarius, C.F.; Chan, C.T.; Floras, J.S. Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter. Am. J. Physiol. Heart Circ. Physiol., 2008, 294(2), H605-H612.
228. Boocock, D.J.; Faust, G.E.; Patel, K.R.; Schinas, A.M.; Brown, V.A.; Ducharme, M.P.; Booth, T.D.; Crowell, J.A.; Perloff, M.; Gescher, A.J.; Steward, W.P.; Brenner, D.E. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers. Prev., 2007, 16(6), 1246-1252.
229. Rai, G.; Wright, G.; Scott, L.; Beston, B.; Rest, J.; Exton-Smith, An. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia. Curr. Med. Res. Opin., 1990, 11(10), 638-647.
230. Spagnoli, A.; Lucca, U.; Menasce, G.; Bandiera, L.; Cizza, G.; Forloni, G.; Tettamanti, M.; Frattura, L.; Tiraboschi, P.; Comelli, M. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology, 1991, 41(11), 1726-1732.
231. Thal, L.J.; Carta, A.; Clarke, W.R.; Ferris, H.S.; Friedland, R.P.; Petersen, R.C.; Pettigrew, J.W.; Pfeiffer, E.; Raskind, M.A.; Sano, M.; Tuszynski, M.H.; Woolson, R.F. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology, 1996, 47(3), 705-711. (Pubitemid 26307301)
232. Thal, L.J.; Calvani, M.; Amato, A.; Carta, A. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD. Neurology, 2000, 55(6), 805-810. (Pubitemid 30727720)
233. Sharma, R.A.; Gescher, A.J.; Steward, W.P. Curcumin: the story so far. Eur. J. Cancer, 2005, 41(13)., 1955-1968.
234. Volak, L.P.; Ghirmai, S.; Cashman, J.R.; Court, M.H. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab. Dispos., 2008, 36, 1594-1605.
235. Appiah-Opong, R.; Commandeur, J.N.; van Vugt-Lussenburg, B.; Vermeulen, N.P. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology, 2007, 235, 83-91.
236. Hayeshi, R.; Mutingwende, I.; Mavengere, W.; Masiyanise, V.; Mukanganyama, S. The inhibition of human glutathione Stransferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem. Toxicol., 2007, 45, 286-295. (Pubitemid 44854313)
237. Zhou, S.; Koh, H.L.; Gao, Y.; Gong, Z.Y.; Lee, E.J. Herbal bioactivation: the good, the bad and the ugly. Life. Sci., 2004, 74(8), 935-968. (Pubitemid 37522131)
238. Basu, N.K.; Ciotti, M.; Hwang, M.S.; Kole, L.; Mitra, P.S.; Cho, J.W.; Owens, I.S. Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyl-transferases enhance potential to control chemical uptake. J. Biol. Chem., 2004, 279, 1429-1441.
239. Oetari, S.; Sudibyo, M.; Commandeur, J.N.; Samhoedi, R.; Vermeulen, N.P. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem. Pharmacol., 1996, 51, 39-45. (Pubitemid 26020677)
240. Correia, M. A Drug Biotransformation. In Katzung, B.G.; Ed.; Basic. and. Clinical. Pharmacology, 10th ed. The McGraw-Hill Companies, New York, 2007; pp. 50-63.
241. Mancuso, C.; Barone, E. Curcumin in clinical practice: myth or reality? Trends Pharmacol. Sci., 2009, 30, 333-334.
242. Zhou, S.; Yung Chan, S.; Cher Goh, B:, Chan, E.; Duan, W.; Huang, M.; McLeod, H.L. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin. Pharmacokinet., 2005, 44(3), 279-304.
243. Scapagnini, G.; Foresti, R.; Calabrese, V.; Giuffrida Stella, A.M.; Green, C.J.; Motterlini, R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol. Pharmacol., 2002, 61(3), 554-561. (Pubitemid 34171921)
244. Shibahara, S. The heme oxygenase dilemma in cellular homeostasis: new insights for the feedback regulation of heme catabolism. Tohoku. J. Exp. Med., 2003., 200(4), 167-186. (Pubitemid 37406931)
245. Shibahara, S.; Nakayama, M.; Kitamuro, T.; Udono-Fujimori, R.; Takahashi, K. Repression of heme oxygenase-1 expression as a defense strategy in humans. Exp. Biol. Med. (Maywood), 2003, 228(5), 472-473. (Pubitemid 37203662)
246. Kitamuro, T.; Takahashi, K.; Ogawa, K.; Udono-Fujimori, R.; Takeda, K.; Furuyama, K.; Nakayama, M.; Sun, J.; Fujita, H.; Hida, W.; Hattori, T.; Shirato, K.; Igarashi, K.; Shibahara, S. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J. Biol. Chem., 2003, 278(11), 9125-9133. (Pubitemid 36800393)
247. Nakayama, M.; Takahashi, K.; Kitamuro, T.; Yasumoto, K.; Katayose, D.; Shirato, K.; Fujii-Kuriyama, Y.; Shibahara, S. Repression of heme oxygenase-1 by hypoxia in vascular endothelial cells. Biochem. Biophys. Res. Commun., 2000, 271(3), 665-671. (Pubitemid 30444685)